Management of osteoarthritis in the primary-care setting: An evidence-based approach to treatment

被引:75
作者
Lane, NE [1 ]
Thompson, JM [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA
关键词
D O I
10.1016/S0002-9343(97)90005-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The most prevalent musculoskeletal condition that results in joint pain is osteoarthritis (OA), with nearly 70% of the population >65 years of age demonstrating radiographic evidence of this disease. The knee is the joint commonly affected. Therapy for OA of the knee is directed at decreasing joint pain and increasing function and includes both pharmacologic and nonpharmacologic interventions. Pharmacologic therapy begins with analgesic medications and proceeds to topical analgesics and nonsteroidal anti-inflammatory drugs (NSAIDs) as needed. Intra-articular injections of corticosteroids can relieve pain and inflammation but the effect is of very short duration and such therapy should only be employed infrequently. Nonpharmacologic therapy should include patient education, weight loss if clinically indicated, physical therapy directed at maintaining joint mobility and strengthening muscle groups or an organized low-impact exercise program, and assistive devices as needed. Total joint replacement appears to be a successful therapy when joint pain severely limits a patient's ability to function. Experimental therapies to modify pain and function in OA patients include intra-articular injections of hyaluronan or arthroscopic joint lavage and debridement. In summary, both pharmacologic and nonpharmacologic measures can contribute to the treatment of pain from OA of the knee. (C) 1997 by Excerpta Medica, Inc.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 53 条
[1]   The role of viscosupplenentation with hylan G-F 20 (Synvisc(R)) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone [J].
Adams, ME ;
Atkinson, MH ;
Lussier, AJ ;
Schulz, JI ;
Siminovitch, KA ;
Wade, JP ;
Zummer, M .
OSTEOARTHRITIS AND CARTILAGE, 1995, 3 (04) :213-225
[2]  
ALTMAN RD, 1994, ARTHRITIS RHEUM, V29, P133
[3]  
Altman Roy D., 1994, Seminars in Arthritis and Rheumatism, V23, P25, DOI 10.1016/S0049-0172(10)80023-X
[4]  
AMADIO P, 1983, CURR THER RES CLIN E, V34, P59
[5]  
Barradell L B, 1993, Pharmacoeconomics, V3, P140, DOI 10.2165/00019053-199303020-00007
[6]  
BATCHLOR EE, 1992, OSTEOARTHRITIS DIAGN, P465
[7]   DONT THROW AWAY THE CANE [J].
BLOUNT, WP .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1956, 38 (03) :695-711
[8]   COMPARISON OF AN ANTIINFLAMMATORY DOSE OF IBUPROFEN, AN ANALGESIC DOSE OF IBUPROFEN, AND ACETAMINOPHEN IN THE TREATMENT OF PATIENTS WITH OSTEOARTHRITIS OF THE KNEE [J].
BRADLEY, JD ;
BRANDT, KD ;
KATZ, BP ;
KALASINSKI, LA ;
RYAN, SI .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (02) :87-91
[9]  
BROOKS PM, 1991, NEW ENGL J MED, V324, P1716
[10]   A RANDOMIZED, CONTROLLED TRIAL OF ARTHROSCOPIC SURGERY VERSUS CLOSED-NEEDLE JOINT LAVAGE FOR PATIENTS WITH OSTEOARTHRITIS OF THE KNEE [J].
CHANG, RW ;
FALCONER, J ;
STULBERG, SD ;
ARNOLD, WJ ;
MANHEIM, LM ;
DYER, AR .
ARTHRITIS AND RHEUMATISM, 1993, 36 (03) :289-296